Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (3478)	4/20/2001 11:34:37 AM
From: Biomaven	Read Replies (2) of 52153

Some interesting strength in a few of my holdings amidst the weakness today. Must be something going on with GLIA - this move is much too big to be accounted for by the European regulatory development. Maybe another takeover in the offing, or possibly they have the FDA happier or maybe they are partnering (or selling) their H3 antagonists. (I still have a few shares that weren't worth selling at the bottom). TELK has also been strong of late. Maybe ASCO related? SCIO benefits from the Actelion failure today. Why CALP and QTRN are each up about 10% today I have no idea. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next